The application of proton pump inhibitors in cardiovascular disease needs to be individualized.

Wang, Xi-Liang; Liu, Jia-Hui; Mo, De-Gang

Wang, Xi-Liang; Liu, Jia-Hui; Mo, De-Gang.

Afiliación

Wang XL; Department of Gastroenterology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China.
Liu JH; Department of Cardiology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China.
Mo DG; Department of Cardiology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China. 1285296769@qq.com.

Cardiovasc Drugs Ther ; 36(6): 1247-1248, 2022 12.

Article en En | MEDLINE | ID: mdl-36272044

Asunto(s)

Enfermedades Cardiovasculares; Inhibidores de la Bomba de Protones; Humanos; Inhibidores de la Bomba de Protones/efectos adversos; Enfermedades Cardiovasculares/diagnóstico; Enfermedades Cardiovasculares/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de la Bomba de Protones Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google